DC
TFFP

Diametric Capital’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Diametric Capital’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,315
Closed -$446K – 183
2021
Q1 		$446K Buy
+1,315
New +$535K 0.34% 77

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Diametric Capital's TFFP Position: Q2 2021 in Review

Diametric Capital sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2021, closing a stake of 1,315 shares — an estimated $446K sold.

Diametric Capital first reported a position in TFFP in Q1 2021 and held it in 1 quarter. The position peaked at $446K in Q1 2021. 59 funds tracked by Wall St. Rank hold TFFP as of Q2 2021.

  • Diametric Capital reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Diametric Capital sold 1,315 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $446K.
  • Diametric Capital first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Diametric Capital's TFF Pharmaceuticals, Inc. Common Stock position peaked at $446K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Diametric Capital's 13F filing for Q2 2021, filed 16 Aug 2021.